New Drug Development Services
Luminex
Luminex technology is an advanced multiplex detection technology, particularly suitable for the simultaneous detection of various cytokines and biomarkers. For preclinical evaluation of tumor immunotherapy, our Luminex cytokine detection platform provides researchers with precise and multiplex data on cytokines and other immune response-related proteins.
Platform Features:
•Based on Luminex technology: Utilizing color-coded microspheres and flow cytometry technology to ensure high sensitivity and specificity.
•Multiplex Detection: Capable of simultaneously detecting multiple cytokines, improving experimental efficiency and data richness.
•Small Sample VolumeOnly 25μL of serum is needed for the detection in accompanying experiments, which reduces the costs of sample preparation.
•Wide Application: Particularly suitable for cytokine release experiments, providing key data for drug screening and evaluation.
Application in Preclinical Drug Evaluation of Tumors and Tumor Immunity:
•Cytokine Multiplex Quantitative Analysis: Capable of accurately determining the levels of various cytokines, providing comprehensive data support for evaluating the effectiveness of immunotherapy.
•Cytokine Release Experiments: Providing experimental basis for drug screening and evaluation, supporting the development of immunotherapy.
Why Choose OurLuminexCytokine Detection Platform:
•Leading Technology: Our platform is based on advanced Luminex technology, ensuring the accuracy and reliability of detection results.
•One-Stop Service: From sample processing to data analysis, we provide comprehensive support.
•Team Experience: Our team has extensive detection experience, providing strong technical support for your research.
Changes in Peripheral Blood Cytokines After T Cell Reconstruction
• Safety testing of immunotherapy and cell therapy
• Immune cell function testing